About Labstr
The future of
insights is now.
Labstr was built for one reason: pharmaceutical research moves slower than the questions it's trying to answer. We fix that — honest voice interviews at scale, transcripts by morning, themes by lunch.
Research at the
speed of the question.
Labstr exists because the gap between asking a question and getting a trustworthy answer from the right physicians has always been measured in weeks. We believe it should be measured in hours.
Scale without sacrifice
200-physician n's that feel like qual, not quantity. Every respondent answers in their own voice. Every transcript is verbatim. Nothing is averaged before you've read the source.
Compliance as the design
Consent, sourcing, adverse-event flagging, and data residency aren't add-ons. They're in the architecture. Pharma's constraints aren't obstacles — they're the spec.
Honest by construction
Labstr doesn't synthesize before you've seen the data. Every theme is pinned to the quotes that earned it. Every number has an n. If the data doesn't carry it, we don't assert it.
The people
behind it.
- 10+ years in cybersecurity & enterprise technology
- Former roles at Atos and Orange Cyberdefense
- Senior advisor to large-cap PE firms on cybersecurity & IT strategy
- 10+ years of product & innovation leadership
- Former CPO at Netatmo
- Former Director at Legrand
- 10+ years of engineering experience
- Former Technical Lead at Netatmo
- Full-stack & AI systems engineer
What we
believe.
These aren't values on a wall. They're constraints we designed the product around. If we ever ship something that contradicts them, it's a bug.
- 01
Research should feel like a conversation with a careful colleague, not a form.
A survey extracts answers. An interview earns them. Labstr is built around the second kind — voice, open-ended, probing. The data is better because the conversation is real.
- 02
Speed is not a shortcut. It's a discipline.
Eleven days from brief to readout isn't fast because we skipped steps. It's fast because we did the hard systems work so you don't have to. Rigor and speed are not opposites.
- 03
Every number needs an n. Every theme needs a quote.
We don't assert things the data can't carry. If 54% of cardiologists said something, you'll see 54%, n=108/200, and the three quotes that earned that theme. Evidence-first, always.
- 04
Compliance isn't a checklist. It's the architecture.
We didn't build a research tool and bolt on compliance. We built a compliant platform that happens to be a great research tool. Consent, sourcing, and adverse-event detection are in the foundation, not the finish.
- 05
Pharma moves slow. Insights shouldn't have to.
Drug development takes a decade. That's not changing. But the question of how physicians actually make decisions today — that one should be answerable this week. We close that gap.